Exploring the oncoproteomic response of human prostate cancer to therapeutic radiation using data-independent acquisition (DIA) mass spectrometry.
Simon Paul KeamTwishi GulatiCristina GamellFranco CaramiaCheng HuangRalf B SchittenhelmOded KleifeldPaul J NeesonYgal HauptScott G WilliamsPublished in: The Prostate (2018)
In this prospective study, we have established a sensitive and reliable oncoproteomic pipeline for the analysis of both fresh and formalin-fixed human PCa tissue. We identified multiple pathways known to be radiation-responsive and have established a powerful database of candidates and pathways with no current association with RT. This information may be beneficial in the advancement of personalized therapies and potentially, predictive biomarkers.